Clinicopathologic characteristics and outcome of patients with different EGFR mutations | |
Zhou, Shengyu; Hu, Xingsheng; Wang, Yan; Li, Junling; Zhou, Liqiang; Hao, Xuezhi; Liu, Yutao; Shi, Yuankai | |
2019 | |
卷号 | 15期号:3页码:166-171 |
关键词 | EGFR-tyrosine kinase inhibitors icotinib nonsmall cell lung cancer uncommon EGFR mutations |
ISSN号 | 1743-7555 |
DOI | 10.1111/ajco.13072 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6345952 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Zhou, Shengyu,Hu, Xingsheng,Wang, Yan,et al. Clinicopathologic characteristics and outcome of patients with different EGFR mutations[J],2019,15(3):166-171. |
APA | Zhou, Shengyu.,Hu, Xingsheng.,Wang, Yan.,Li, Junling.,Zhou, Liqiang.,...&Shi, Yuankai.(2019).Clinicopathologic characteristics and outcome of patients with different EGFR mutations.,15(3),166-171. |
MLA | Zhou, Shengyu,et al."Clinicopathologic characteristics and outcome of patients with different EGFR mutations".15.3(2019):166-171. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论